Spontaneous pneumothorax during nintedanib therapy in patients with systemic sclerosis‐associated interstitial lung disease

Interstitial lung disease (ILD) is a common complication of systemic sclerosis (SSc). Nintedanib, an antifibrotic drug, has recently been approved for treating SSc‐ILD. Although there have been no reports suggesting the development of pneumothorax with nintedanib use, its safety in patients with imp...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Respirol Case Rep
Main Authors: Sumi, Toshiyuki, Uehara, Hirofumi, Tada, Makoto, Keira, Yoshiko, Kamada, Koki, Shijubou, Naoki, Yamada, Yuichi, Nakata, Hisashi, Mori, Yuji, Chiba, Hirofumi
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Ltd 2021
Teme:
Case Reports
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7840496/
https://ncbi.nlm.nih.gov/pubmed/33552523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rcr2.716
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki